WHO ICTRP trial
Efficacy and Safety of AAE581 in postmenopausal women with…
JPRN-jRCT2080220152 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT2080220152 |
|---|---|
| Public title | Efficacy and Safety of AAE581 in postmenopausal women with Osteopenia/Osteoporosis. |
| Scientific title | Efficacy and Safety of AAE581 in postmenopausal women with Osteopenia/Osteoporosis. |
| Primary sponsor | Novartis Pharma K.K. |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | 2 |
| Conditions | Osteoporosis |
| Interventions | investigational material(s) Generic name etc : AAE581 INN of investigational material : Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : Oral |
| Registration date | Oct 20, 2005 |
| Target size | 160 |
| Secondary IDs | JapicCTI-050154 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: